Q3 2016 13F Holders as of 9/30/2016
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
52.3M
-
Number of holders
-
108
-
Total 13F shares, excl. options
-
23.7M
-
Shares change
-
-478K
-
Total reported value, excl. options
-
$121M
-
Value change
-
-$2.79M
-
Number of buys
-
55
-
Number of sells
-
-41
-
Price
-
$5.09
Significant Holders of ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) as of Q3 2016
118 filings reported holding ENZB - ENZO BIOCHEM INC - Common Stock, par value $0.01 per share as of Q3 2016.
ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) has 108 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23.7M shares
of 52.3M outstanding shares and own 45.37% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (4.1M shares), RENAISSANCE TECHNOLOGIES LLC (1.96M shares), DIMENSIONAL FUND ADVISORS LP (1.89M shares), BlackRock Institutional Trust Company, N.A. (1.56M shares), VANGUARD GROUP INC (1.48M shares), ACADIAN ASSET MANAGEMENT LLC (1.25M shares), BlackRock Fund Advisors (1.11M shares), First Light Asset Management, LLC (1.05M shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (875K shares), and GILDER GAGNON HOWE & CO LLC (872K shares).
This table shows the top 108 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.